Skip to content
Catalyst

taurineFinding

Taurine decreases malondialdehyde (circulating)

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Tau supplementation can reduce the levels of malondialdehyde (MDA) (SMD = -1.17 µmol/l; 95% CI: -2.08, - 0.26; P = 0.012) and C-reactive protein (CRP) (SMD = -1.95 mg/l; 95% CI: -3.20, - 0.71; P = 0.002).”
Quoted verbatim from Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.
This finding among the 37 findings on its endpoint

taurine

Malondialdehyde (circulating)

lowers

Effect as reported

−1.17standardised mean difference

CI −2.08 to −0.26

Who
participants in controlled clinical trials of taurine supplementation
Dose studied
not reported

Very limited evidencePMID 34584225 · 2022

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

03 · The paper

European journal of clinical nutrition
What else it reported4 findings · 1 compound · 4 endpoints

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6ZT919MYVXW2VCHEB4J0729